drugset / Trial / NCT04921124
Pharmacokinetic and PHarmacodynamic Analysis and Evaluation of Teriparatide (PTH 1-34) Between Sexes
Phase 3
Completed
30 enrolled
Norfolk and Norwich University Hospitals NHS Foundation Trust
Ministry of Defence, United Kingdom · collabUniversity of East Anglia · collab
NaSingle-groupOpen-labelOther
Summary
To test for a difference in the pharmacokinetics (PK) and pharmacodynamics (PD) of teriparatide (PTH 1-34), between healthy male and female volunteers matched to military recruits in training.
Timeline
- Start
- 2021-05-24
- Primary completion
- 2021-07-05
- Completion
- 2021-07-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Teriparatide | Protein / enzyme biologic | 20 ug | Subcutaneous |
Indications
No indication recorded.